News on Boehringer Mannheim GmbH from BioPortfolio.com http://www.BioPortfolio.com Consolidated Boehringer Mannheim GmbH news from BioPortfolio.com Tue, 09 Feb 2010 23:42:10 GMT en RFID Cabinet Maker Expands Overseas Productionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036931&HITNO=0&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036931&THISHREF=http://c.moreover.com/click/here.pl%3fz2536829731%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036931&HITNO=0&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036931&THISHREF=http://c.moreover.com/click/here.pl%3fz2536829731%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDiagnostic & Invasive Cardiology: Experienced Global Biotech Executive Joins biOasis as Executive Vice Presidenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033891&HITNO=1&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033891&THISHREF=http://c.moreover.com/click/here.pl%3fz2535475043%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033891&HITNO=1&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033891&THISHREF=http://c.moreover.com/click/here.pl%3fz2535475043%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTech Divas: Hepatitis C Virus: Research in the area of hepatitis C virus reported from Boehringer Ingelheim GmbH, Department of Biological Scienceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033358&HITNO=2&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033358&THISHREF=http://c.moreover.com/click/here.pl%3fz2535162672%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033358&HITNO=2&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033358&THISHREF=http://c.moreover.com/click/here.pl%3fz2535162672%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Experienced Global Biotech Executive Joins biOasis as Executive Vice Presidenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029821&HITNO=3&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029821&THISHREF=http://c.moreover.com/click/here.pl%3fz2533287504%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029821&HITNO=3&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029821&THISHREF=http://c.moreover.com/click/here.pl%3fz2533287504%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Experienced Global Biotech Executive Joins biOasis as Executive Vice Presidenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029326&HITNO=4&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029326&THISHREF=http://c.moreover.com/click/here.pl%3fz2533090446%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029326&HITNO=4&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029326&THISHREF=http://c.moreover.com/click/here.pl%3fz2533090446%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Experienced Global Biotech Executive Joins biOasis as Executive Vice Presidenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029260&HITNO=5&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029260&THISHREF=http://c.moreover.com/click/here.pl%3fz2533056707%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029260&HITNO=5&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029260&THISHREF=http://c.moreover.com/click/here.pl%3fz2533056707%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInterest!ALERT: Experienced Global Biotech Executive Joins biOasis as Executive Vice Presidenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029257&HITNO=6&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029257&THISHREF=http://c.moreover.com/click/here.pl%3fz2533055675%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029257&HITNO=6&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029257&THISHREF=http://c.moreover.com/click/here.pl%3fz2533055675%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGlobeNewswire via Yahoo!: Experienced Global Biotech Executive Joins biOasis as Executive Vice Presidenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029236&HITNO=7&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029236&THISHREF=http://c.moreover.com/click/here.pl%3fz2533045037%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029236&HITNO=7&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029236&THISHREF=http://c.moreover.com/click/here.pl%3fz2533045037%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Dyskinesia: Researchers at Boehringer Ingelheim GmbH target dyskinesiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024775&HITNO=8&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024775&THISHREF=http://c.moreover.com/click/here.pl%3fz2529159757%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024775&HITNO=8&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024775&THISHREF=http://c.moreover.com/click/here.pl%3fz2529159757%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: First Deal for Apeiron a Doozy: Getting up to $329M from GSKhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013086&HITNO=9&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013086&THISHREF=http://c.moreover.com/click/here.pl%3fz2523605415%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013086&HITNO=9&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013086&THISHREF=http://c.moreover.com/click/here.pl%3fz2523605415%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioWorld: First Deal for Apeiron a Doozy: Getting up to $329M from GSKhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009978&HITNO=10&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009978&THISHREF=http://c.moreover.com/click/here.pl%3fz2522184318%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009978&HITNO=10&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009978&THISHREF=http://c.moreover.com/click/here.pl%3fz2522184318%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Rib-X Pharmaceuticals appoints new board memberhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954341&HITNO=11&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954341&THISHREF=http://c.moreover.com/click/here.pl%3fz2492639138%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954341&HITNO=11&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954341&THISHREF=http://c.moreover.com/click/here.pl%3fz2492639138%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Rib-X Pharmaceuticals appoints new board member - Zibb.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954309&HITNO=12&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954309&THISHREF=http://c.moreover.com/click/here.pl%3fz2492622378%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954309&HITNO=12&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954309&THISHREF=http://c.moreover.com/click/here.pl%3fz2492622378%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: The Automation Partnership Appoints Phillip Sefton as New Commercial Director To Spearhead the Launch of New Phttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954143&HITNO=13&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954143&THISHREF=http://c.moreover.com/click/here.pl%3fz2492483390%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954143&HITNO=13&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954143&THISHREF=http://c.moreover.com/click/here.pl%3fz2492483390%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Rib-X Elects MedImmune's Peter Greenleaf to Its Board - Zibb.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952109&HITNO=14&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952109&THISHREF=http://c.moreover.com/click/here.pl%3fz2490594611%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952109&HITNO=14&MSIZE=54&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boehringer%20Mannheim%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952109&THISHREF=http://c.moreover.com/click/here.pl%3fz2490594611%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: